Michelle Thi Cao, MD
Critical Care (Intensivists) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 6
Offices
6 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cao’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$95,198
Medicare paid this office $95,198 for 539 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 78 | $29,605 | $182 |
| Long return visit (40+ min) | 82 | $17,036 | $159 |
| Return visit (30+ min) | 71 | $9,164 | $115 |
| New patient visit (45+ min) | 47 | $6,347 | $135 |
| Long return visit (40+ min) | 31 | $4,785 | $126 |
See all 22 services
| Critical care, first 30-74 minutes | 78 | $29,605 | $182 |
| Long return visit (40+ min) | 82 | $17,036 | $159 |
| Return visit (30+ min) | 71 | $9,164 | $115 |
| New patient visit (45+ min) | 47 | $6,347 | $135 |
| Long return visit (40+ min) | 31 | $4,785 | $126 |
| New patient visit (30+ min) | 41 | $4,318 | $105 |
| Critical care, each additional 30 minutes | 27 | $3,425 | $93 |
| New patient visit (60+ min) | 17 | $3,238 | $190 |
| Short return visit (20+ min) | 19 | $1,638 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,282 | $117 |
| Sleep study including heart rate, breathing, and sleep time | 21 | $1,281 | $61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 57 | $1,044 | $15 |
| Test to examine how well the lungs exchange gases | 115 | $889 | $8 |
| Test to determine lung volumes using sensors | 82 | $858 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 93 | $848 | $9 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 25 | $635 | $22 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | 15 | $510 | $34 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 19 | $329 | $15 |
| Test to measure expiratory airflow and volume | 35 | $251 | $7 |
| Test to examine how well the lungs exchange gases | 23 | $154 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $107 | $8 |
| Test to measure expiratory airflow and volume | 14 | $93 | $7 |
Who their Medicare patients are
539 Original Medicare patients in 2024. Average age 72 · Under 65 14% · 85 and older 11% · Women 56% · Also on Medicaid 27% · Health risk score 2.26. Sicker patients than 9 in 10 peers; the typical sleep medicine clinician is at 1.21.
Conditions among them: High blood pressure 70% · Coronary heart disease 35% · COPD 34% · Chronic kidney disease 30% · Diabetes 29% · Heart failure 28% · Atrial fibrillation 28% · Depression 28% · Cancer 21% · Dementia 10% · Stroke 10%.
The office billed $687,713, Medicare allowed $123,322 and paid $95,198; for 1,215 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 539 | 1,215 | 72 | 2.26 | $687,713 | $95,198 |
| 2023 | 482 | 1,006 | 72 | 2.22 | $594,574 | $81,290 |
| 2022 | 587 | 1,320 | 73 | 2.22 | $795,307 | $111,938 |
| 2021 | 240 | 547 | 68 | 1.78 | $375,280 | $57,029 |
| 2020 | 180 | 304 | 67 | 2.10 | $136,452 | $27,106 |
| 2019 | 417 | 586 | 69 | 1.48 | $199,504 | $53,206 |
| 2018 | 393 | 577 | 69 | 1.61 | $160,112 | $50,686 |
| 2017 | 427 | 633 | 69 | 1.50 | $215,863 | $54,866 |
| 2016 | 439 | 668 | 69 | 1.50 | $252,878 | $55,505 |
| 2015 | 464 | 677 | 70 | 1.29 | $262,143 | $56,499 |
| 2014 | 345 | 431 | 70 | 1.12 | $154,587 | $34,346 |
| 2013 | 329 | 461 | 70 | 1.17 | $173,562 | $34,231 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Critical care, first 30-74 minutes | 74 | $28,610 | $189 |
| Long return visit (40+ min) | 58 | $9,493 | $128 |
| Long return visit (40+ min) | 50 | $7,410 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $5,962 | $103 |
| New patient visit (60+ min) | 31 | $4,718 | $152 |
| Critical care, each additional 30 minutes | 20 | $4,562 | $95 |
| New patient visit (60+ min) | 29 | $4,200 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,079 | $160 |
| Return visit (30+ min) | 24 | $1,962 | $75 |
| New patient visit (45+ min) | 17 | $1,726 | $102 |
| Return visit (30+ min) | 13 | $1,084 | $83 |
| Test to examine how well the lungs exchange gases | 80 | $605 | $7 |
| Test to determine lung volumes using sensors | 52 | $516 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 57 | $497 | $9 |
| Sleep study including heart rate, breathing, and sleep time | 12 | $477 | $34 |
| Test to examine how well the lungs exchange gases | 47 | $380 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 37 | $347 | $9 |
| Test to measure expiratory airflow and volume | 34 | $254 | $7 |
| Test to measure expiratory airflow and volume | 30 | $221 | $7 |
| Test to determine lung volumes using sensors | 19 | $208 | $11 |
2022: 22 services
| Critical care, first 30-74 minutes | 89 | $45,469 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $14,802 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,947 | $183 |
| Long return visit (40+ min) | 53 | $8,165 | $117 |
| Long return visit (40+ min) | 36 | $5,374 | $114 |
| New patient visit (60+ min) | 31 | $4,587 | $148 |
| Hospital discharge day management, more than 30 minutes | 29 | $2,875 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,814 | $122 |
| New patient visit (60+ min) | 16 | $2,570 | $161 |
| Critical care, each additional 30 minutes | 13 | $1,924 | $96 |
| Return visit (30+ min) | 18 | $1,858 | $88 |
| New patient visit (45+ min) | 16 | $1,840 | $115 |
| Return visit (30+ min) | 15 | $1,506 | $84 |
| Test to examine how well the lungs exchange gases | 105 | $810 | $7 |
| Test to determine lung volumes using sensors | 66 | $662 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 70 | $603 | $8 |
| Test to examine how well the lungs exchange gases | 70 | $562 | $8 |
| Test to measure expiratory airflow and volume | 66 | $478 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 43 | $407 | $9 |
| Sleep study including heart rate, breathing, and sleep time | 11 | $336 | $31 |
| Test to measure expiratory airflow and volume | 42 | $312 | $6 |
| Test to determine lung volumes using sensors | 29 | $310 | $11 |
2021: 11 services
| Long return visit (40+ min) | 85 | $21,574 | $127 |
| Long return visit (40+ min) | 42 | $7,017 | $119 |
| Critical care, first 30-74 minutes | 16 | $6,663 | $196 |
| New patient visit (60+ min) | 30 | $4,840 | $161 |
| New patient visit (60+ min) | 21 | $4,126 | $196 |
| Return visit (30+ min) | 27 | $3,146 | $95 |
| Return visit (30+ min) | 14 | $1,222 | $81 |
| Sleep study including heart rate, breathing, and sleep time | 14 | $583 | $39 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $510 | $30 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 13 | $386 | $23 |
| Test to examine how well the lungs exchange gases | 17 | $139 | $8 |
2020: 6 services
| Long return visit (40+ min) | 79 | $10,675 | $89 |
| Long return visit (40+ min) | 38 | $4,619 | $94 |
| Return visit (30+ min) | 31 | $2,252 | $70 |
| New patient visit (60+ min) | 12 | $1,723 | $144 |
| Return visit (30+ min) | 19 | $1,457 | $73 |
| New patient visit (60+ min) | 12 | $915 | $76 |
2019: 12 services
| Long return visit (40+ min) | 73 | $10,822 | $94 |
| Return visit (30+ min) | 122 | $8,428 | $64 |
| New patient visit (60+ min) | 46 | $6,859 | $149 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 60 | $6,413 | $107 |
| Sleep study in sleep lab (6 years or older) | 54 | $5,905 | $107 |
| Long return visit (40+ min) | 33 | $3,088 | $83 |
| New patient visit (45+ min) | 29 | $2,926 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,753 | $184 |
| Return visit (30+ min) | 30 | $2,225 | $60 |
| New patient visit (60+ min) | 16 | $2,080 | $130 |
| Short return visit (20+ min) | 15 | $597 | $40 |
| Test to measure expiratory airflow and volume | 11 | $85 | $8 |
2018: 9 services
| Return visit (30+ min) | 172 | $12,740 | $64 |
| New patient visit (60+ min) | 74 | $9,583 | $129 |
| Long return visit (40+ min) | 64 | $7,867 | $94 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 58 | $6,227 | $106 |
| New patient visit (45+ min) | 37 | $3,905 | $106 |
| Long return visit (40+ min) | 30 | $3,093 | $97 |
| Sleep study in sleep lab (6 years or older) | 29 | $3,051 | $105 |
| Short return visit (20+ min) | 22 | $1,004 | $46 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $578 | $53 |
2017: 8 services
| Return visit (30+ min) | 238 | $18,701 | $66 |
| New patient visit (60+ min) | 75 | $10,042 | $134 |
| Long return visit (40+ min) | 74 | $9,269 | $96 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 57 | $6,702 | $110 |
| Sleep study in sleep lab (6 years or older) | 37 | $3,936 | $104 |
| New patient visit (45+ min) | 37 | $3,755 | $101 |
| Sleep study including heart rate, breathing, airflow, and effort | 13 | $662 | $51 |
| Short return visit (20+ min) | 12 | $548 | $42 |
2016: 8 services
| Return visit (30+ min) | 245 | $19,844 | $64 |
| New patient visit (60+ min) | 64 | $9,405 | $147 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 70 | $8,325 | $112 |
| Long return visit (40+ min) | 63 | $7,517 | $95 |
| Sleep study in sleep lab (6 years or older) | 51 | $5,396 | $106 |
| New patient visit (45+ min) | 32 | $2,895 | $90 |
| Short return visit (20+ min) | 36 | $1,535 | $41 |
| Short return visit | 18 | $369 | $19 |
2015: 9 services
| Return visit (30+ min) | 221 | $17,829 | $66 |
| New patient visit (60+ min) | 66 | $9,442 | $143 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 65 | $7,718 | $113 |
| Sleep study in sleep lab (6 years or older) | 67 | $6,922 | $103 |
| Long return visit (40+ min) | 59 | $6,060 | $98 |
| New patient visit (45+ min) | 25 | $2,894 | $116 |
| Short return visit (20+ min) | 62 | $2,699 | $41 |
| Return visit (30+ min) | 12 | $728 | $61 |
| Short return visit | 19 | $432 | $23 |
2014: 7 services
| Return visit (30+ min) | 171 | $12,522 | $65 |
| New patient visit (60+ min) | 35 | $5,178 | $148 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 42 | $4,677 | $109 |
| Long return visit (40+ min) | 42 | $4,098 | $89 |
| Sleep study in sleep lab (6 years or older) | 34 | $3,534 | $104 |
| New patient visit (45+ min) | 17 | $1,909 | $112 |
| Short return visit (20+ min) | 45 | $1,812 | $38 |
2013: 6 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 74 | $8,110 | $108 |
| Short return visit (20+ min) | 136 | $7,023 | $43 |
| New patient visit (45+ min) | 61 | $6,817 | $112 |
| Return visit (30+ min) | 72 | $5,544 | $68 |
| Sleep study in sleep lab (6 years or older) | 37 | $3,998 | $105 |
| New patient visit (30+ min) | 12 | $706 | $59 |
Medicaid work
$4,404 in 2024
Medicaid paid $4,404 for 58 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 28 | $4,167 |
| Diffusing capacity | 18 | $124 |
| EVALUATION OF WHEEZING | 12 | $113 |
| 2024 | 58 | 3 | 18 | $4,404 |
| 2023 | 45 | 3 | 17 | $1,073 |
| 2022 | 55 | 3 | 16 | $206 |
| 2021 | 17 | 1 | 17 | $363 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 15 | $843 |
| EVALUATION OF WHEEZING | 13 | $142 |
| Diffusing capacity | 17 | $88 |
2022
| EVALUATION OF WHEEZING | 12 | $99 |
| Diffusing capacity | 29 | $76 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 14 | $32 |
2021
| Long return visit (40+ min) | 17 | $363 |
Drugs they prescribed that Part D paid
$20,864
Pharmacies billed $20,864 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 114) in 2024. At or below the middle of the specialty; the typical sleep medicine clinician is at 0%.
50 generic and 64 brand-name prescriptions · $20,864 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 12 | $7,200 | $600 |
| Breo Ellipta | 11 | $4,525 | $411 |
| Budesonide-Formoterol | 13 | $2,942 | $226 |
| Albuterol Sulfate Hfa | 21 | $580 | $28 |
| Ipratropium | 14 | $454 | $32 |
Year by year
| 2024 | 114 | 36 | 0% (0) | 56% | $20,864 |
| 2023 | 105 | 28 | None | 49% | $17,061 |
| 2022 | 109 | 38 | None | 33% | $21,240 |
| 2021 | 60 | 15 | 0% (0) | 40% | $9,686 |
| 2020 | 55 | 14 | 0% (0) | 35% | $3,979 |
| 2019 | 38 | 22 | 0% (0) | None | $14,902 |
| 2018 | 52 | 24 | None | 31% | $39,808 |
| 2017 | 88 | 33 | None | 42% | $11,653 |
| 2016 | 97 | 36 | None | 25% | $10,271 |
| 2015 | 121 | 41 | None | None | $3,438 |
| 2014 | 134 | 29 | 15% (20) | None | $10,200 |
| 2013 | 43 | 16 | None | None | $9,407 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Fluticasone-Salmeterol | 12 | $1,085 | $90 |
| Albuterol Sulfate Hfa | 17 | $725 | $43 |
| Ipratropium | 13 | $622 | $48 |
2022: 3 drugs
| Albuterol Sulfate Hfa | 13 | $635 | $49 |
| Ipratropium | 17 | $400 | $24 |
| Gabapentin | 15 | $244 | $16 |
2021: 2 drugs
| Ipratropium | 14 | $431 | $31 |
| Gabapentin | 14 | $110 | $8 |
2020: 1 drug
| Gabapentin | 16 | $121 | $8 |
2018: 1 drug
| Fluticasone Propionate | 11 | $128 | $12 |
2017: 1 drug
| Gabapentin | 13 | $88 | $7 |
2016: 2 drugs
| Fluticasone Propionate | 20 | $254 | $13 |
| Gabapentin | 20 | $134 | $7 |
2015: 2 drugs
| Zolpidem | 13 | $178 | $14 |
| Fluticasone Propionate | 14 | $117 | $8 |
Money from drug and device companies
$28 in 2025
| 2025 | 1 | 1 | None | $28 |
| 2023 | 2 | 3 | None | $152 |
| 2022 | 1 | 1 | None | $20 |
| 2020 | 4 | 5 | $6,433 | $6,787 |
| 2019 | 2 | 2 | $3,396 | $3,495 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Zepbound | $28 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2025-04-09 | Zepbound | $28 |
See earlier years (2023, 2022, 2020, 2019)
2023: $152
| Jazz Pharmaceuticals | Xywav | $102 | 2 payments
|
| Breas Medical | Vivo 45 Ls | $50 | 1 payment
|
2022: $20
| AstraZeneca Pharmaceuticals LP | Fasenra | $20 | 1 payment
|
2020: $6,787
| Genzyme | Lumizyme | $4,753 | 2 payments
|
| Genentech | Evrysdi | $1,680 | 1 payment
|
| W. L. Gore & Associates | Bio-A Tissue Reinforcement | $301 | 1 payment
|
| GlaxoSmithKline | None | $53 | 1 payment
|
2019: $3,495
| Genzyme | Lumizyme | $3,396 | 1 payment
|
| W. L. Gore & Associates | Seamguard Bioabsorbable Staple Line Reinforcement | $99 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386791762
- Licence
- CA 20A8008
- Trained
- Western Eclectic College of Medicine and Surgery, 2000
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00AX80080
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-01-05
- NPI last updated
- 2024-12-12
- NPI record certified
- 2024-12-12
This is when the NPI record was last certified, not a medical board exam.